|
---|
Category:Letter
MONTHYEARML23229A0202023-08-17017 August 2023 Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001 ML23087A2272023-05-0505 May 2023 Shine Technologies, LLC - Issuance of Amendment No. 4 to Construction Permit No. CPMIF-001 for the Receipt and Possession of Contained Special Nuclear Material ML23086C0502023-04-27027 April 2023 Shine Technologies, LLC - Letter, Environmental Assessment and Finding of No Significant Impact ML23088A3382023-04-0505 April 2023 Shine Technologies, LLC - Review of the Physical Security Plan in Support of an Operating License for a Medical Radioisotope Production Facility ML23010A1982023-02-24024 February 2023 Shine Technologies, LLC - Letter: Safety Evaluation Report for the Shine Medical Radioisotope Production Facility Operating License Application ML23048A2442023-02-17017 February 2023 Shine Technologies, LLC Request to Amend Construction Permit No. CPMIF-001 Response to Request for Additional Information ML23034A1872023-02-0303 February 2023 Shine Medical Technologies, LLC Notice of Availability of Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility (Docket Number: 50-608) ML23010A2382023-02-0303 February 2023 Shine Technologies, LLC - Individual Notice of Consideration FRN Letter ML23023A0942023-02-0202 February 2023 Notice of Availability of the Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML23023A0922023-02-0202 February 2023 Notice of Availability of the Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML23023A0862023-02-0202 February 2023 Notice of Availability of the Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML23024A1682023-02-0101 February 2023 Letter to Ken Westlake, EPA Region 5 - Issuance of Final EIS Supplement Related to the Operating License ML23024A1742023-02-0101 February 2023 Dr. Gregory Piefer, Chief Executive Officer - Issuance of Final EIS Supplement Related to the Operating License ML22287A1852023-02-0101 February 2023 Shine Technologies, LLC Regulatory Report on the Audit of Phased Startup Operations Application Supplement ML22308A2332023-01-0909 January 2023 Shine Technologies LLC - Regulatory Audit Report for Chapter 8 - Irradiation Facility and Radioisotope Production Facility Electrical Power Systems ML22347A2142023-01-0404 January 2023 Shine Technologies LLC - Regulatory Audit Report for I&C Combined Sessions ML22356A1932022-12-22022 December 2022 Shine Technologies, LLC Application for an Operating License - Response to Request for Confirmatory Information ML22347A1772022-12-14014 December 2022 Shine Technologies LLC - Regulatory Audit Report for Programmable Logic Lifecycle ML22301A1492022-12-0707 December 2022 Shine Technologies, LLC - Regulatory Audit Report for Chapter 13 - Accident Analysis and Criticality Safety ML22322A2122022-12-0202 December 2022 Shine Medical Technologies - Cybersecurity Audit Summary Report ML22322A2232022-12-0202 December 2022 Shine Medical Technologies - Fire Protection Audit Summary Report ML22348A0672022-12-0101 December 2022 Shine Technologies, LLC - Request for Confirmatory Information Related to Instrumentation and Control Systems ML22335A5722022-12-0101 December 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22292A3192022-11-30030 November 2022 Shine Medical Technologies, LLC Issuance of Order and Amendment No. 3 to Construction Permit No. CPMIF-001 ML22318A1782022-11-14014 November 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22304A1262022-10-31031 October 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22279A9512022-10-0606 October 2022 Shine Technologies, LLC Request to Amend Construction Permit No. CPMIF-001 ML22271A9632022-09-28028 September 2022 Shine Technologies, LLC Application for an Operating License Supplement No. 31 Revision to the Phased Startup Operations Application Supplement ML22263A3442022-09-20020 September 2022 Shine Technologies, LLC Application for an Operating License - Response to Request for Additional Information ML22263A0272022-09-19019 September 2022 Shine Technologies, LLC - Application for an Operating License - Response to Request for Confirmatory Information ML22220A2612022-09-12012 September 2022 Shine Technologies LLC - Regulatory Report on the Audit Chapter 14, Technical Specifications ML22251A3272022-09-0808 September 2022 Shine Technologies, LLC Application for an Operating License Revision 1 of Shine Response to Requests for Additional Information 7-38, 7-40, and 7-48 ML22249A1252022-08-31031 August 2022 Shine Technologies, LLC Final Safety Analysis Report - Application for an Operating License Supplement No. 30, Cover Letter ML22105A1102022-08-26026 August 2022 Shine Medical Technologies LLC - Request for Additional Information Related to the OGC Review of Phrase Approach ML22061A2122022-08-24024 August 2022 Shine Medical Technologies LLC - Regulatory Audit Plan for Phased Approach - Session 1 ML22213A0492022-08-0101 August 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22187A1342022-08-0101 August 2022 Shine Technologies, LLC - Update to Operating License Application Technical Review Schedule ML22206A2082022-07-27027 July 2022 Shine Medical Technologies, LLC - Request for Confirmatory Information Related to Radiation Protection Program and Waste Management ML22207A0062022-07-26026 July 2022 Shine Technologies, LLC Application for an Operating License Supplement No. 29 ML22202A4492022-07-21021 July 2022 Shine Technologies, LLC Operating License Application Supplement No. 28 - Submittal of a Revision to the Shine Emergency Plan ML22188A2412022-07-14014 July 2022 Meeting with Shine Medical Technologies, LLC (EPID No. L-2019-NEW-0004), to Discuss Development of Shine'S Cybersecurity Program for It'S Medical Isotope Production Facility ML22175A0392022-07-11011 July 2022 Letter to Reid Nelson, Achp Notice of Availability and Request for Comments on the Draft EIS Supplement Related to the Operating License for the Shine Facility ML22175A0542022-07-0808 July 2022 Letter to Gregory Piefer - Notice of Availability of the Draft EIS Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML22175A0912022-07-0808 July 2022 Notice of Availability and Request for Comments on the Draft Environmental Impact Statement Supplement Related to the Operating License for the Shine (Multiple Tribal Letters) ML22175A0772022-07-0808 July 2022 Letter to Daina Penkiunas - Notice of Availability and Request for Comments on the Draft EIS Supplement Related to the Operating License for the Shine Facility ML22175A0632022-07-0808 July 2022 Letter to Ken Westlake, EPA Region 5 - Notice of Availability and Request for Comments on the Draft EIS Supplement Related to the Operating License for the Shine Facility ML22188A1942022-07-0707 July 2022 Shine Technologies, LLC, Application for an Operating License Supplement No. 27 ML22188A0562022-07-0707 July 2022 Shine Technologies, LLC Operating License Application Supplement No. 26 Submittal of a Revision to the Shine Material Control and Accounting Plan ML22223A0662022-07-0606 July 2022 Shine Technologies, LLC, Application for an Operating License, Revision 1 of the Response to Requests for Additional Information Related to Cyber Security ML22175A0742022-07-0101 July 2022 Letter to Mary Buelow Maintenance of Reference Materials at the Hedberg Public Library for the Environmental Review of Shine Medical Technologies, LLC Operating License Application 2023-08-17
[Table view] Category:Response to Request for Additional Information (RAI)
MONTHYEARML23048A2442023-02-17017 February 2023 Shine Technologies, LLC Request to Amend Construction Permit No. CPMIF-001 Response to Request for Additional Information ML22356A1932022-12-22022 December 2022 Shine Technologies, LLC Application for an Operating License - Response to Request for Confirmatory Information ML22335A5722022-12-0101 December 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22318A1782022-11-14014 November 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22304A1262022-10-31031 October 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22263A3442022-09-20020 September 2022 Shine Technologies, LLC Application for an Operating License - Response to Request for Additional Information ML22263A0272022-09-19019 September 2022 Shine Technologies, LLC - Application for an Operating License - Response to Request for Confirmatory Information ML22178A0352022-06-27027 June 2022 Enclosure 2 - Shine Technologies, LLC Application for an Operating License Revision 1 of the Shine Response to Requests for Additional Information 9-8 and 9-9 ML22143A8142022-05-23023 May 2022 Shine Technologies, LLC, Application for an Operating License Response to Request for Additional Information ML22112A1952022-04-22022 April 2022 Shine Technologies, LLC Application for an Operating License - Response to Request for Additional Information ML22094A0452022-04-0404 April 2022 Shine Technologies, LLC - Application for an Operating License Revision 1 of Shine Response to Part (C) of Request for Additional Information 7-9 ML22077A0862022-03-18018 March 2022 Shine Technologies, LLC Application for an Operating License - Supplement No. 20 and Response to Request for Additional Information ML22059A0202022-02-28028 February 2022 Enclosure 2: Shine Technologies, LLC - Response to Request to Additional Information ML22032A3422022-02-0101 February 2022 Shine Technologies, LLC, Application for an Operating License Revision 1 of the Shine Response to Request for Additional Information 11-2 ML22028A2242022-01-28028 January 2022 Shine Technologies, LLC, Response to Request for Additional Information on Application for an Operating License ML21364A0552021-12-30030 December 2021 Shine Technologies, LLC, Application for an Operating License Response to Request for Additional Information ML21350A1912021-12-16016 December 2021 Shine Technologies, LLC - Application for an Operating License Response to Request for Additional Information ML21326A2092021-11-22022 November 2021 Enclosure 3: Response to Request for Additional Information - Public Version ML21307A3062021-11-0303 November 2021 Shine Technologies, LLC, Application for an Operating License Response to Request for Additional Information ML21272A3442021-09-29029 September 2021 Shine Medical Technologies, LLC - Response to Request for Additional Information (Public Version) ML21271A0762021-09-28028 September 2021 Shine Medical Technologies, LLC, Application for an Operating License Revision 1 of Shine Response to Request for Additional Information 3.4-12 ML21243A2692021-08-31031 August 2021 Enclosure 2 - Response to Request for Additional Information Public Version ML21239A0492021-08-27027 August 2021 Shine Medical Technologies, LLC Application for an Operating License Response to Request for Additional Information ML21232A5872021-08-20020 August 2021 Shine Medical Technologies, LLC - Application for an Operating License Response to Request for Additional Information ML21232A6202021-08-20020 August 2021 Shine Medical Technologies, LLC Request to Amend Construction Permit No. CPMIF-001 - Response to Request for Additional Information ML21232A6232021-08-20020 August 2021 Enclosure 3: Request to Amend Construction Permit No. CPMIF-001 Response to Request for Additional Information ML21232A6212021-08-20020 August 2021 Enclosure 1: Request to Amend Construction Permit No. CPMIF-001 Response to Request for Additional Information ML21208A1352021-07-27027 July 2021 Shine Medical Technologies, LLC Application for an Operating License Response to Request for Additional Information ML21183A1282021-07-0202 July 2021 Enclosure 2: Shine Medical Technologies, LLC, Application for an Operating License, Response to Request for Additional Information Public Version ML21154A3032021-06-0303 June 2021 Shine Medical Technologies, LLC Application for an Operating License Response to Request for Additional Information 4a-15 ML21127A0512021-05-0707 May 2021 Shine Medical Technologies, LLC Application for an Operating License Response to Request for Additional Information ML21095A2352021-03-23023 March 2021 Shine Medical Technologies, LLC, Cover Letter for Response to Request Tor Additional Information and Supplement No. 7 ML21095A2292021-03-23023 March 2021 Shine Medical Technologies, LLC, Response to Request for Additional Information and Supplement No. 7 ML21075A0122021-03-16016 March 2021 Shine Medical Technologies, LLC - Application for an Operating License, Revision 1 of Shine Response to Request for Additional Information 2.4-1 ML21029A1032021-01-29029 January 2021 Enclosure 1 - Response to Final Safety Analysis Report Chapters 2, 3, and 8 Requests for Additional Information ML21029A1052021-01-29029 January 2021 Enclosure 3 - Response to Final Safety Analysis Report Chapters 6 and 13 Requests for Additional Information ML21022A0272021-01-22022 January 2021 Shine Medical Technologies, LLC Application for an Operating License, Response to Environmental Requests for Additional Information ML21011A2402020-12-15015 December 2020 Shine Medical Technologies, LLC - Operating License Application Supplement No. 6 and Response to Request for Additional Information ML20357A0872020-12-10010 December 2020 Enclosure 3 - Response to Request for Additional Information ML20255A0282020-08-28028 August 2020 Enclosure 1 - Response to Request for Additional Information ML20188A3022020-06-17017 June 2020 Shine Medical Technologies, LLC - Response to Request for Additional Information on Operating License Application ML20129J9202020-05-0808 May 2020 Shine Medical Technologies, LLC, Application for an Operating License Response to Supplemental Environmental Requests for Additional Information ML20073E8802020-03-13013 March 2020 Shine Medical Technologies, LLC Application for an Operating License Response to Environmental Requests for Additional Information ML19071A0562019-03-0808 March 2019 Shine Medical Technologies, Inc., Affidavit & Response to Request for Additional Information to Application for Order Approving Indirect Transfer of Control of Construction Permit Response to Request for Additional Information ML17040A1382017-02-0707 February 2017 Shine Medical Technologies, Inc. Safeguards Information (SGI) Protection Program Response to Request for Additional Information ML15259A0242015-09-15015 September 2015 Shine Medical Technologies, Inc. - Application for Construction Permit, Revision 1 of Shine Response to Request for Additional Information 6b.3-34 ML15247A0672015-09-0202 September 2015 Shine Medical Technologies, Inc. Application for Construction Permit Response to Request for Additional Information ML15258A5982015-08-27027 August 2015 Enclosure 2 - Revision 1 of the Shine Response to RAI 12.1-1 and RAI 12.2-1 ML15222A2422015-07-23023 July 2015 Enclosure 2 - Attachment 3 - Atkins-NS-DAC-SHN-15-02, Revision 0 ML15222A2442015-07-23023 July 2015 Enclosure 2 - Attachment 2 - Atkins-NS-DAC-SHN-15-04, Revision 0 2023-02-17
[Table view] |
Text
October 31, 2022 2022-SMT-0114 10 CFR 50.30 U.S. Nuclear Regulatory Commission ATTN: Document Control Desk Washington, DC 20555
References:
(1) SHINE Medical Technologies, LLC letter to the NRC, SHINE Medical Technologies, LLC Application for an Operating License, dated July 17, 2019 (ML19211C143)
(2) NRC electronic mail to SHINE Technologies, LLC, Request to Confirm Information FSAR Chapter 13, Accident Analysis, dated October 28, 2022 SHINE Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information Pursuant to 10 CFR Part 50.30, SHINE Technologies, LLC (SHINE) submitted an application for an operating license for a medical isotope production facility to be located in Janesville, Wisconsin (Reference 1). The NRC staff determined that confirmatory information was required to enable the staffs continued review of the SHINE operating license application (Reference 2).
Enclosure 1 provides the SHINE responses to the NRC staffs request for confirmatory information.
If you have any questions, please contact Mr. Jeff Bartelme, Director of Licensing, at 608/210-1735.
I declare under the penalty of perjury that the foregoing is true and correct.
Executed on October 31, 2022.
Very truly yours, James Costedio Vice President of Regulatory Affairs and Quality SHINE Technologies, LLC Docket No. 50-608 Enclosure cc: Project Manager, USNRC SHINE General Counsel Supervisor, Radioactive Materials Program, Wisconsin Division of Public Health 3400 Innovation Ct
- www.SHINEtechnologies.com
ENCLOSURE 1 SHINE TECHNOLOGIES, LLC SHINE TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE RESPONSE TO REQUEST FOR CONFIRMATORY INFORMATION The U.S. Nuclear Regulatory Commission (NRC) staff determined that confirmatory information was required (Reference 1) to enable the continued review of the SHINE Technologies, LLC (SHINE) operating license application (Reference 2). The following information is provided by SHINE in response to the NRC staffs request.
RCI 13-1 For the accident-specific materials-at-risk described in SHINE FSAR Section 13a2.2, Accident Analysis and Determination of Consequences, confirm the following the following information:
For the accident specific material-at-risk (MAR) for the maximum hypothetical accident, the analysis deterministically assumes that 25 percent of iodine in the TSV solution in initially within the TSV offgas system (TOGS). It is assumed that the iodine in solution is predominantly volatile and that aqueous to gas partitioning occurs rapidly, causing 100% of the iodine inventory to be released to TOGS post shutdown. SHINE conservatively assumes that 100% of the safety-basis MAR is released.
SHINE Response SHINE confirms the information related to the accident-specific materials-at-risk described in Section 13a2.2 of the FSAR is accurate.
RCI 13-2 For the identification of control volumes and leakage paths in SHINE FSAR Section 13a2.2, confirm the following information:
SHINE identified the control volumes, leakage paths, and heat sinks that define the model geometry. The control volumes used in the analysis include the source volume, the building volume, and the environment. Leakage paths are treated as junctions between the control volumes.
The analysis considers each part of the facility as a fixed volume that the material is free to disperse into. Dispersion within these volumes is assumed to be instantaneous. Each volume is connected by one or more junctions which allows flow in one direction at a volumetric flow rate, either pressure-driven or constant. Counter-current flow, or flow back into the previous control volume, is not considered in this calculation.
Page 1 of 6
The SHINE-identified scenarios can be organized into four leak-path combinations which include: release location, initial confinement, secondary confinement, and release to environment. These leak-path combinations are:
- 1. Confinement by IU Cell or concrete cell -> IF building -> environment;
- 2. Confinement by glovebox -> IF building -> environment;
- 3. Confinement by hot cell -> RPF building -> environment; and
- 4. Confinement by concrete vault -> RPF building -> environment.
SHINE Response SHINE confirms the information related to the identification of control volumes and leakage paths in Section 13a2.2 of the FSAR is accurate, with one clarification. For the release from a tritium purification system (TPS) glovebox (Scenario 7 of CALC-2018-0048, Radiological Dose Consequences), the release scenario also considers the volume of the TPS room in the leak path, such that the appropriate leak-path combination for item 2 of the list is: confinement by glovebox -> TPS room -> IF building -> environment.
RCI 13-3 For the derivation of iodine reduction factors in SHINE FSAR Section 13a2.2, confirm the following the following information:
SHINE utilized the following model and guidance to perform this analysis:
- Iodine partitioning was calculated using equations based on the definitions found in NUREG/CR-5950, Iodine Evolution and pH Control.
- Bursting bubble aerosols are treated using a linear relationship between entrainment coefficients and the volumetric flow rate with entrainment coefficients consistent with the small amount of dissolved materials present in the target solution.
- Spray and free-fall aerosols use a constant airborne release fraction found in NUREG/CR-6410.
- Radiolysis was treated as either an instantaneous release of hydrogen or as entrainment with source generation based on decay power inputs for long-term problems.
All scenarios containing iodine use isotope reduction factors that account for TOGS running during normal operations. Scenarios that are downstream from the IU cell take an additional removal factor of iodine due to the operation of the TOGS during the post-irradiation dump tank hold time.
SHINE calculation, CALC-2018-0048, Appendix B, Justification for Treatment of Iodine, contains the justification for the removal factors that are utilized in this calculation as well as the isotope-specific reduction factors. The table below provides a list for each DBA scenarios which assumes iodine removal factors for the IU, the dump tank, or both.
Page 2 of 6
Design-Basis Accident Scenarios Utilizing Iodine Removal Factors Irradiation Dump Tank Scenario Reduction Reduction Number Factor Factor 1a x 1b x 3 x 9a x x 9b x x 10 x 11 x x 12 x x 14 x x SHINE Response SHINE confirms the information related to the models, guidance, and assumptions made in examined scenarios used to derive the iodine reduction factors in Section 13a2.2 of the FSAR is accurate.
RCI 13-4 For the quantification of leak rates between volumes in SHINE FSAR Section 13a2.2, confirm the following information:
SHINE defined leakage rates between volumes driven by pressure, gas density differences, and barometric breathing. The outcome of this sub-step as expressions for removal rates. The gas pressure in each volume is determined using a combination of conservation laws for mass and energy, temperature-dependent specific heats, and the ideal gas law. Pressure-driven flow through each junction was calculated using the standard compressible flow equation for pressure-driven flow. Pressure-driven flow through shielding cover plug gaps was calculated using the equation for plane Poiseuille flow. In the absence of pressure-driven flow, counter-current flow was assumed to be induced and was calculated based on the difference in pressure from one side of the cover plug to the other. There is no assumed flow from the IF to the RPF or vice versa; all material in the IF or RPF control volumes exits the SHINE facility to the environment.
SHINE Response SHINE confirms the information related to the quantification of leak rates between volumes identified in Section 13a2.2 of the FSAR is accurate.
RCI 13-5 For the quantification of removal mechanisms in SHINE FSAR 13a2.2, confirm the following information:
SHINE established expressions for removal rates of radionuclides. Specifically, iodine adsorption, non-volatile aerosol deposition, and removal by filters along flow paths. Removal by Page 3 of 6
aerosol settling was evaluated using Stokes law and the calculated equilibrium particle size for a hygroscopic particle. Consideration of removal by filters in the accident flow paths was done by assigning decontamination factors for noble gases, iodine, and aerosols to each filter.
Removal due to barometric breathing was based on an analysis of the peak-to-peak magnitude of environmental pressure fluctuations. Eight years of pressure data were collected and analyzed to provide a bounding estimate of the barometric breathing flow rate for the facility.
SHINE Response SHINE confirms the information related to the established expressions for the removal rates of radionuclides in Section 13a2.2 of the FSAR is accurate.
RCI 13-6 For assessing meteorological conditions in SHINE FSAR Section 13a2.2, confirm the following:
The x/Q values are calculated for periods of 0-2 hours, 0-8 hours, 8-24 hours, 1-4 days, and 4-30 days following the effluent release.
The control room atmospheric dispersion x/Q values utilized in the SHINE accident analysis are reported in CALC-2018-0048 Rev. 6, Table 3-1, 95th Percentile Site Boundary x/Q values, are as follows:
Time Bin (hours)
Locations 0-2 2-8 8-24 24-96 96-720 Control Room Public 1.40E-2 1.09E-2 4.61E-3 2.99E-3 2.33E-3 x/Q Values (s/m3)
SHINE Response SHINE confirms the control room atmospheric dispersion x/Q values utilized in the SHINE accident analysis are accurate.
RCI 13-7 For operator radiological consequences assumptions in SHINE FSAR Section 13a.2.2, confirm the following:
The volume of the control room is conservatively estimated to be 350 m3 based on the dimensions of the control room minus estimated sizes of the equipment in the control room.
SHINE assumes no cross contamination from IF and RPF as the control room is not part of the radiologically control area. Therefore, the radionuclide flow path from the material at risk source to the control room is accident-dependent but generally flows to the environment to the facility ventilation system intake (FVZ4) using the control room atmospheric c/Q values. The facility ventilation zone four system is responsible for delivering air to the control room and many other rooms in the non-radiologically controlled area of the SHINE facility where approximately 20% of the FVZ4 inlet flow is delivered to the control room. The FVZ4 is assumed to continue running after all initiating events as it is not safety-related. Material that reaches the control room are assumed to instantaneously diffuses within the control room volume. The ventilation system is Page 4 of 6
assumed to continue running after all initiating events for a period of 30 days. The breathing rate for control room operators is 3.50E-04 m3/s based on those stated in RG 1.195 for the duration of the scenario. Control room occupancy factors are sourced from RG 1.195 item 4.2.6 as described below:
Control Room Occupancy Factors 0-24 hours 24-96 hours96-720 hours Occupancy Factor 1.0 0.6 0.4 SHINE Response SHINE confirms the identified estimates and assumptions used to calculate radiological dose consequences to operators in the control room are accurate.
RCI-13-8 For public radiological consequences assumptions in SHINE FSAR Section 13a.2.2, confirm the following:
The public radiological consequences are computed by modeling the radionuclide flow path from the material at risk source to the environment in combination with the siting public atmospheric c/Q values over a 30-day period. The breathing rate for control room operators is 3.50E-04 m3/s based on those stated in RG 1.195 for the duration of the scenario.
SHINE Response SHINE confirms the identified modeling approach and assumed breathing rate used to calculate the radiological dose consequences to the public are accurate.
RCI 13-9 TS 5.5.1, Nuclear Safety Program, states, in part, the following:
The safety program accomplishes these goals through development and maintenance of the accident analysis, identification of safety-related controls credited for the prevention or mitigation of accidents, and establishment of programmatic administrative controls to ensure reliability of the credited controls.
Confirm that TS 5.5.1 will ensure that the SHINE Safety Analysis and its supporting documentation remain accurate and current, including prompt updates of the SHINE Safety Analysis and its supporting documentation when a change is made to the facility, operations, or FSAR descriptions.
SHINE Response SHINE confirms that Section 5.5.1 of the Technical Specifications ensures the SHINE Safety Analysis and its supporting documentation will remain accurate and current, including prompt updates when changes are made to the facility, operations, or FSAR descriptions.
Page 5 of 6
References
- 1. NRC electronic mail to SHINE Technologies, LLC, Request to Confirm Information FSAR Chapter 13, Accident Analysis, dated October 28, 2022
- 2. SHINE Medical Technologies, LLC letter to the NRC, SHINE Medical Technologies, LLC Application for an Operating License, dated July 17, 2019 (ML19211C143)
Page 6 of 6